Cite
Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1.
MLA
Carvill, Gemma L., et al. “Targeted Resequencing in Epileptic Encephalopathies Identifies de Novo Mutations in CHD2 and SYNGAP1.” Nature Genetics, vol. 45, no. 7, July 2013, pp. 825–30. EBSCOhost, https://doi.org/10.1038/ng.2646.
APA
Carvill, G. L., Heavin, S. B., Yendle, S. C., McMahon, J. M., O’Roak, B. J., Cook, J., Khan, A., Dorschner, M. O., Weaver, M., Calvert, S., Malone, S., Wallace, G., Stanley, T., Bye, A. M. E., Bleasel, A., Howell, K. B., Kivity, S., Mackay, M. T., Rodriguez-Casero, V., & Webster, R. (2013). Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1. Nature Genetics, 45(7), 825–830. https://doi.org/10.1038/ng.2646
Chicago
Carvill, Gemma L, Sinéad B Heavin, Simone C Yendle, Jacinta M McMahon, Brian J O’Roak, Joseph Cook, Adiba Khan, et al. 2013. “Targeted Resequencing in Epileptic Encephalopathies Identifies de Novo Mutations in CHD2 and SYNGAP1.” Nature Genetics 45 (7): 825–30. doi:10.1038/ng.2646.